cetylpyridinium chloride anhydrous and saquinavir

cetylpyridinium chloride anhydrous has been researched along with saquinavir in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bittner, B; Grange, S; Holmes, B; Riek, M	1

Trials

1 trial(s) available for cetylpyridinium chloride anhydrous and saquinavir

Article	Year
Saquinavir 500 mg film-coated tablets demonstrate bioequivalence to saquinavir 200 mg hard capsules when boosted with twice-daily ritonavir in healthy volunteers. Antiviral therapy, 2005, Volume: 10, Issue:7 Topics: Adult; Aged; Anti-HIV Agents; Area Under Curve; Capsules; Cross-Over Studies; Drug Administration Schedule; Female; Half-Life; Health; Humans; Male; Middle Aged; Ritonavir; Saquinavir; Tablets; Therapeutic Equivalency	2005

Article

Year

Saquinavir 500 mg film-coated tablets demonstrate bioequivalence to saquinavir 200 mg hard capsules when boosted with twice-daily ritonavir in healthy volunteers.

Antiviral therapy, 2005, Volume: 10, Issue:7

Topics: Adult; Aged; Anti-HIV Agents; Area Under Curve; Capsules; Cross-Over Studies; Drug Administration Schedule; Female; Half-Life; Health; Humans; Male; Middle Aged; Ritonavir; Saquinavir; Tablets; Therapeutic Equivalency

2005